Dr. Wimal Samarasinghe Dissanayake, MD

Dr. Dissanayake practices at Rochester General Hospital in Rochester, New York, part of Rochester Regional Health.

Dr. Dissanayake's NPI, 1902069503, was assigned on July 3, 2008. Dr. Dissanayake graduated from University of Colombo Faculty of Medicine in 2000. Dr. Dissanayake holds New York license 275493.

Dr. Dissanayake's primary practice is Rochester General Hospital, at 1425 Portland Avenue, Rochester, NY 14621 in Monroe County. The practice phone is (585) 922-4000.

Dr. Dissanayake's primary practice is Rochester General Hospital in Rochester, New York, part of Rochester Regional Health. Dr. Dissanayake is also affiliated with Clifton Springs Hospital and Clinic. The medical group on file is Rochester General Hospital. Dmand AI also links Dr. Dissanayake to 1 more hospital and 3 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Dissanayake practices, 3 sites in all. Vendor and product names are available with a free account.

Hospitalist is Dr. Dissanayake's primary specialty in the NPI Registry, under taxonomy code 208M00000X. Dr. Dissanayake is licensed in New York.

CMS data shows 370 Medicare services from Dr. Dissanayake across 4 procedure codes in 2024, for 149 Medicare patients. Medicare paid $29,650 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 149 Medicare patients who saw Dr. Dissanayake in 2024. The largest group is under 65, with 42 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 60% are also on Medicaid. Their average risk score is 2.90, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Dissanayake's median patient age at 76, with 50% women.

In 2024, Dr. Dissanayake wrote 181 Medicare Part D claims for 74 patients. 83% of them were for generic drugs. CMS names the drug for 42 of them, across 3 drugs with 11 or more claims each, at $247 in total drug cost. In 2022, CMS named 43 claims across 3 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 97 out of 100 for Dr. Dissanayake for performance year 2024, reported through an alternative payment model (APM). Dr. Dissanayake accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 2 general payments to Dr. Dissanayake from 2 drug and device companies from 2018 to 2019. Food and beverage make up the largest share, 100% of the total. Janssen Pharmaceuticals, Inc paid the most, $15.

Dr. Dissanayake graduated from University of Colombo Faculty of Medicine in 2000.